title: Prevalence of Helicobacter pylori infection and the incidence of ureA and clarithromycin resistance gene 23S rRNA genotypes status in Saudi Arabia.
abstract: OBJECTIVE
  To determine the prevalence of Helicobacter pylori ureA and clarithromycin resistance gene 23S rRNA genotypes among H. pylori in Saudi Arabia.
  
  
  METHODS
  A total of 100 serum and fecal samples from 70 patients and 30 healthy volunteers, from patients who presented with symptoms suggestive of gastritis or peptic ulcer disease, were taken from the main hospital in the Southern region of Saudi Arabia from September 2010 C.E. to March 2011 C.E. corresponding to Shawwal 1431 A.H. to Rabi Al-Thani 1432 A.H. We cultured the samples for H. pylori and a polymerase chain reaction was carried out to check for the presence or absence of ureA gene and clarithromycin resistance gene 23S rRNA genotypes.
  
  
  RESULTS
  Among the 70 suspected patients, the suspected bacteria isolated from the fecal samples of 60, (85.7%) were positive using the culture techniques. The presence of ureA gene and clarithromycin resistance gene 23S rRNA was determined by using the polymerase chain reaction, Among the 100 fecal specimens, 65 fecal specimens from 70% patients showed positive results to clarithromycin resistance gene 23S rRNA (sensitivity, 93%; Specificity, 100% and Accuracy, 95%), Only 60 fecal specimens were positive with ureA gene (sensitivity, 86%; Specificity, 100% and Accuracy, 90%).
  
  
  CONCLUSIONS
  23S rRNA gene was associated with clarithromycin resistance in H. pylori. There was a high prevalence of H. pylori resistance to clarithromycin in Saudi Arabia. H. pylori is a neutrophilic bacteria that has been able to colonize the human stomach by using a variety of acid-adaptive mechanisms as Urease activity that hydrolyzed the Urea producing 2 NH3 and H2CO3.
authors: Jazan University, Academic Campus for Girls, Jazan, PO Box: 755, Saudi Arabia.
authors: Marwah M
authors: MM
authors: Bakri
keywords: Helicobacter pylori
references: Am J Gastroenterol. 1990 Aug;85(8):944-8
references: 2375321
references: Trends Microbiol. 1993 Oct;1(7):255-60
references: 8162405
references: Aliment Pharmacol Ther. 2006 Feb 1;23(3):429-35
references: 16423002
references: Lancet. 1983 Jun 4;1(8336):1273-5
references: 6134060
references: Clin Microbiol Rev. 1997 Oct;10(4):720-41
references: 9336670
references: JAMA. 1999 Dec 15;282(23):2240-5
references: 10605976
references: Dig Dis Sci. 2000 Jan;45(1):68-76
references: 10695616
references: Emerg Infect Dis. 1995 Jul-Sep;1(3):79-85
references: 8903168
references: J Antimicrob Chemother. 2005 Aug;56(2):282-6
references: 15958499
references: Epidemiol Rev. 2000;22(2):283-97
references: 11218379
references: J Epidemiol. 1997 Dec;7(4):251-4
references: 9465552
references: Hepatogastroenterology. 1994 Feb;41(1):48-50
references: 8175115